pulseTV

VIDEO: Triage Considerations for Structural Heart Patients During COVID-19 From ACC and SCAI

Coronavirus (COVID-19) | April 14, 2020

Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center, explains the new American College of Cardiology (ACC) and SCAI precaution guidelines for treating transcatheter aortic valve replacement (TAVR) patients in the cath lab during the COVID-19 pandemic.

He explains recommendations for how structural heart programs can continue to treat acutely ill patients during novel coronavirus (COVID-19, SARS-CoV-2) containment efforts. The key message in the guidelines is to defer patients who can wait until containemnt efforts loosen in the coming months, while acute patients who are very sick should be treated.

The guidelines are outlined in the document "Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID‐19) Pandemic: An ACC /SCAI Consensus Statement." can be accessed online in the SCAI journal Catheterization and Cardiovascular Interventions.[1]

 

Related COVID-19 Cardiology Content:

VIDEO: Impact of COVID-19 on the Cardiovascular Program at Henry Ford Hospital — Interview with William O’Neill, M.D.

First Large-scale U.S. Study on Hydroxychloroquine COVID-19 Prophylaxis Begins in Detroit

New York City Physicians Note Multiple Cardiovascular Presentations of COVID-19

VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with Ehtisham Mahmud, M.D.

ACC COVID-19 recommendations for the cardiovascular care team

VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients

FDA Approves ECMO to Treat COVID-19 Patients

COVID-19 STEMI Registry Created to Study Acute Cardiovascular Effects of the Virus

Image Gallery Showing Impact of the COVID-19 Pandemic

VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic

The Cardiac Implications of Novel Coronavirus

 

 

Reference:

1. Pinak B. Shah, Frederick G.P. Welt, Ehtisham Mahmud, et al. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID‐19) Pandemic: An ACC /SCAI Consensus Statement. Catheterization and Cardiovascular Interventions. First published:06 April 2020 https://doi.org/10.1002/ccd.28910.

Conference Coverage

Information Technology | April 23, 2015

DAIC/ITN Editor Dave Fornell shows examples of new healthcare IT technology at the 2015 HIMSS meeting that will change the future of healthcare. These include healthcare wearable devices, smart phone apps, virtual training software, population health data, and technology for patient engagement.  See more exampled of how consumer healthcare technology is rapidly evolving in the VIDEO: Wearable Health Monitors and Apps at the 2018 Consumer Electronics Show.
 

 

Information Technology | April 22, 2015

The Centers for Medicare and Medicaid (CMS) has issue a draft list Stage 3 Meaningful Use requirements. Jeff Coughlin, senior director, federal and state affairs, Health Information and Management Systems Society (HIMSS), explains what these requirements include at the HIMSS 2015 annual meeting.

Wearables | April 22, 2015

At HIMSS 2015, one of the biggest trends was the explosion of consumer health related wearable devices and smartphone apps and how these will integrate into the healthcare system for improved patient monitoring and patient engagement. Thomas Martin, HIMSS director of health information systems, explains this trend and where these devices will fit in during the coming years. Read the article "How Wearables, Smartphones and Apps May Change the Face of Healthcare."
 

 

Enterprise Imaging | April 22, 2015

During HIMSS 2015, Louis Lannum, director, ITD enterprise imaging, information technology division, Cleveland Clinic, explained in sessions how to create an enterprise imaging system that goes beyond PACS to service all imaging and data needs of departments in the hospital enterprise.

Enterprise Imaging | April 22, 2015

Mony Weschler, chief applications strategist and architect, application technology services, Montefiore Health System, New York, explains how he integrated enterprise imaging and mobile ECG waveform at Montefiore Health System.

Drug-Eluting Balloons | April 02, 2015

In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease in the SFA. Doug Drachman, M.D., Mass General Hospital, who served a the site principal investigator for the Lutonix balloon trial, explains his experiences and insights with these devices in an interview at ACC 2015. Read the article “Drug-eluting Balloons Enter the U.S. Market.”
 

Cath Lab | March 25, 2015

Hear the latest trends and news on interventional cardiology from the American College of Cardiology (ACC) 2015 meeting in an interview with John Reilly, M.D., FACC, vice chairman of cardiology, Ochsner, New Orleans, and chairman of PR, SCAI.

EP Lab | March 25, 2015

Learn about the trends and new technology in electrophysiology in an interview with David Wilber, M.D., editor of JACC's Clinical EP, and medical director, clinical electrophysiology, director, Cardiovascular Institute, co-director, Cardiovascular Research Institute, Loyola University Medical Center, Chicago.

ACC | March 25, 2015

DAIC Editor Dave Fornell shares his picks of the most interesting new devices and advances in cardiovascular technology shown on the expo floor at the 2015 American College of Cardiology (ACC) meeting.

Heart Failure | March 20, 2015

The results from the CHAMPION Trial for the CardioMEMS device were presented at the American College of Cardiology (ACC) 2015. Principal Investigator William Abraham, M.D., professor, cardiovascular medicine, The Ohio State University, shares trial data and his experience with the system.

Heart Valve Technology | March 20, 2015

Several late-breaking trials for transcatheter aortic valve replacement (TAVR) were presented at the American College of Cardiology (ACC) 2015. Find out some of the insights to that data with Ajay Kirtane, M.D., SM, chief academic officer and director of the interventional cardiology fellowship program, Columbia University Medical Center / New York-Presbyterian Hospital, and CRF/TCT faculty.

Cardiovascular Information Systems (CVIS) | December 18, 2014

Sentara Health in Virginia is going through the process of choosing a new cardiovascular information system (CVIS) and implementing enterprise imaging. Sentara's IT leader shares information on what elements they are looking for and how they plan to wire their system to achieve a new level of interoperability for cardiology. They were at RSNA 2014 visiting with CVIS vendors as part of their selection process. Read the article "10 Questions to Ask When Purchasing a Cardiovascular Information System."
 

 

Information Technology | December 18, 2014

QICS is a unique, automated workflow management solution to help today's medical professionals enhance the delivery of care, reduce risks, optimize user productivity and meet regulatory requirements compliance. QICS can provide workflow efficiencies that help providers improve performance and satisfaction for both physicians and patients. Qualitative Intelligence and Communication System (QICS) solutions can help: Create records for accountability and analytics — Meet regulatory requirements — Reduce manual processes to streamline workflow — Optimize communication to help deliver better care

Enterprise Imaging | December 18, 2014

McKesson is committed to working with facilities to adapt to the new healthcare reality in both an effective and cost-efficient fashion. The vendor does this by providing a suite of enterprise solutions including: McKesson Enterprise Image Repository — Brings together all the scattered images from numerous isolated systems into the image repository (VNA) and helps provide a single view of the patient's imaging history, accessible from anywhere across the enterprise.  McKesson Clinical Data Exchange — Manage, share and access patient images and clinical documents anywhere in the enterprise or across a region from any common Web-enabled device or workstation by leveraging the IHE cross-enterprise document sharing (XDS) integration profile.

RSNA | December 12, 2014

Many of the key trends in radiology seen at the Radiological Society of North America (RSNA) 2014 meeting are discussed by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell.

RSNA | December 12, 2014

Here are ITN Editor Dave Fornell's choices for the most innovative new imaging technologies shown on the expo floor at the Radiological Society of North America (RSNA) 2014 annual meeting.

Cardiovascular Ultrasound | October 17, 2014

Siemens introduces True volume transesophageal echo (TEE) transducer — this 3-D/4-D 90°x90° TEE solution enables clinically meaningful echocardiography visualization of anatomy, volume color Doppler and function in one volume view, without compromises like stitching. Combined with eSieValves advanced cardioac ultrasound analysis package, it offers automated modeling and quantification in seconds allowing cardiologists to remove the guesswork from valve sizing. For more information: usa.healthcare.siemens.com/ultrasound/cardiovascular/acuson-sc2000-ultrasound-system/features

Vascular Closure Devices | September 26, 2014

Doug Drachman, M.D., Mass General Hospital Institute of Heart, Vascular and Stroke Care, explains how to prevent and manage access site complications, use of vascular closure devices and how to aid patient ambulation following PCI.

Intravascular Imaging | September 26, 2014

Ziad Ali, M.D., senior scientist at the Cardiovascular Research Foundation (CRF), discusses the current trials and future possibilities of intravascular near-infrared spectroscopy imaging to identify and pre-treat vulnerable plaque.

Cath Lab | September 26, 2014

DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies discussed in sessions and shown on the expo floor at the Transcatheter Cardiovascular Therapeutics (TCT) 2014 meeting.

Stents Bioresorbable | September 24, 2014

DAIC Editor, Dave Fornell, interviews  Jim Hermiller, M.D., FACC, director of interventional cardiology, St. Vincent Heart Center-Indiana, and a principle investigator in the Absorb III Trial. Read the article "FDA Approves First Totally Bioresorbable Stent."

CT Angiography (CTA) | September 24, 2014

John Stevens, chairman and CEO of HeartFlow, explains his company's computed tomography (CT)-based fractional flow reserve (FFR) assessment technology, which may eliminate the need for catheter-based FFR measurements.

Cardiovascular Information Systems (CVIS) | September 12, 2014

Centricity Cardio Enterprise Solution from GE Healthcare is designed to empower Cardiologists to enhance patient care through full clinical access, optimized productivity and enhanced revenue cycle efficiencies. Omar Sunna, global product manager for GE Healthcare IT, explains some of the highlights of the system at the American College of Cardiology (ACC) 2014 meeting.

Advanced Visualization | July 30, 2014

Toshiba launched its new myocardial perfusion software for computed tomography (CT) during the 2014 American College of College of Cardiology (ACC) annual meeting. Perfusion imaging is now available on both the Aquillion One and Aqullion One Vision CT systems.

CT Angiography (CTA) | July 23, 2014

Society of Cardiovascular Computed Tomography (SCCT) Past President Matthew Budoff, M.D., explains some of the new technology and latest trends seen in cardiac CT during the SCCT 2014 annual meeting in San Diego, Calif.

Cardiovascular Ultrasound | July 18, 2014

The Aplio 500 CV is the system of choice for all premium 2-D cardiac exams. Featuring Toshiba's 2-D Wall Motion Tracking technology, the system provides stunning visualization and quantitative analysis of myocardial wall motion with unrivaled accuracy and reproducibility. With on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal), the Aplio 500 CV system is designed to get the most comprehensive information anytime and anywhere in the hospital, right at the patient's bedside. Additional cardiac-specific technologies include Tissue Enhancement, Advanced Dynamic Flow, Lateral Gain Controls, Tissue Doppler, Stress Echo, Flex-M Mode and Auto IMT. The system is easy to use, with superior ergonomics and a smaller footprint, making it easier to maneuver for greater patient access and improved workflow. For more information: http://medical.toshiba.com/products/ul/cardiovascular/index.php

Cardiovascular Ultrasound | July 03, 2014

DAIC Editor Dave Fornell highlights his choices for some of the most innovative new technology at the American Society of Echocardiography (ASE) 2014 meeting.

Cardiovascular Ultrasound | July 02, 2014

ASE Past President James Thomas, M.D., explains some of the hot topics in cardiovascular ultrasound at the 2014 meeting of the American Society Echocardiography (ASE).

Nuclear Imaging | June 20, 2014

DAIC Editor Dave Fornell shares his choices for the most innovative new technologies in nuclear imaging that were on display at the 2014 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

Nuclear Imaging | June 19, 2014

Satoshi Minoshima, M.D., Ph.D., chairman of the Society of Nuclear Medicine and Molecular Imaging Scientific Committee, discusses the new technologies and trends at SNMMI 2014.

ACC | April 08, 2014

DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies shown on the expo floor at the American College of Cardiology (ACC) 2014 meeting.

Stents Bioresorbable | April 03, 2014

Bioresorbable stent technology was one of the big interventional technologies discussed at the American College of Cardiology (ACC) 2014 meeting. Doug Drachman, M.D., Mass General Hospital, explains where the technology is today and what we will likely see in the future. Read the article "FDA Approves First Totally Bioresorbable Stent."

Heart Valve Technology | April 03, 2014

The biggest late-breaking news to come out of the American College of Cardiology (ACC) 2014 meeting was from the CoreValve High-Risk pivotal trial, which showed a transcatheter valve offers a 26 percent survival benefit over surgical valve replacement. Co-Principal Investigator David Adams, M.D., explained the impact of the trial.

Renal Denervation | April 03, 2014

A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy in the U.S. SYMPLICITY HTN-3 trial. Michael Jaff , D.O., worked as part of the core lab for the trial and explains the trial outcomes and the future of renal denervation technology. He spoke to DAIC at the 2014 American College of Cardiology (ACC) meeting where the trial results were released.

 

Related Renal Denervation Content:

Renal Artery Denervation and Catheter Ablation Increased Freedom From Atrial Fibrillation

VIDEO: Device Therapies to Treat Hypertension

SPYRAL HTN-OFF MED Study Results Show Efficacy, Safety of Renal Denervation

Medtronic Announces Spyral HTN Global Clinical Trial Program for Renal Denervation

Medtronic Randomizes First Patients in Symplicity HTN-4

Medtronic Says its U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint

The Future of Renal Denervation Following the Failed SYMPLICITY HTN-3 Trial

 

Information Technology | March 07, 2014

A big trend in healthcare IT at HIMSS 2014 was the creation of enterprise-wide image access systems. With the introduction of vendor neutral archives (VNAs), enterprise imaging will increasingly be taken out of the hands of radiology and move to the responsibility of hospital IT directors. In this form, radiology may become just another department contributing images to the VNA. HIMSS also highlighted the proliferation of new, inexpensive home use patient monitors.

Cath Lab | November 11, 2013

DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies discussed in sessions and shown on the expo floor at the Transcatheter Cardiovascular Therapeutics (TCT) 2013 meeting.

Heart Valve Technology | November 07, 2013

Scott Lim, M.D., director of the Heart Valve Center at the University of Virginia Medical Center, investigator in the EVEREST and COAPT trials, discusses the MitraClip transcatheter mitral valve repair system at TCT 2013. The device recieved FDA clearance a couple days before TCT.

Read the article "FDA Clears First Transcatheter Mitral Valve Repair Device."
 

November 07, 2013

Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the top interventional cardiology highlights at TCT 2013.

Cardiovascular Ultrasound | July 15, 2013

American Society of Echocardiography (ASE) President Benjamin Byrd III, M.D., FASE, explains some of the recent trends and issues facing cardiac ultrasound. These trends include reimbursement issues, the rapid expansion of point-of-care ultrasound and the critical role played by the new sub-specialty of interventional ultrasound.

Cardiovascular Ultrasound | July 15, 2013

DAIC Editor Dave Fornell highlights some of the biggest trends and most innovative technology discussed during the American Society of Echocardiology (ASE) 2013 annual meeting.